Menu
Currency
GWAS Study

Investigating evidence for a causal association between inflammation and self-harm: A multivariable Mendelian Randomisation study.

Russell AE, Ford T, Gunnell D et al.

32473944 PubMed ID
GWAS Study Type
153560 Participants
63 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

RA
Russell AE
FT
Ford T
GD
Gunnell D
HJ
Heron J
JC
Joinson C
MP
Moran P
RC
Relton C
SM
Suderman M
HG
Hemani G
MB
Mars B
Chapter II

Abstract

Summary of the research findings

The causal role of inflammatory markers on self-harm and suicidal risk has been studied using observational data, with conflicting results. Confounding and reverse causation can lead to bias, so we appraised question from a genetic perspective to protect against these biases. We measured associations between genetic liability for high levels of inflammatory markers Interleukin-6 (IL-6) and C-reactive protein (CRP) on self-harm, and conducted a secondary analysis restricted to self-harm with suicidal intent.

3,470 European ancestry cases, 150,090 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

153560
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.